Literature DB >> 389290

Prostaglandin thromboxane, and 12-hydroxy-5,8,10,14-eicosatetraenoic acid production by ionophore-stimulated rat serosal mast cells.

L J Roberts, R A Lewis, J A Oates, K F Austen.   

Abstract

Production of several metabolites of arachidonic acid by purified rat serosal mast cells in response to stimulation with the ionophore A23187 was assessed by stable isotope dilution assay using gas chromatography-mass spectrometry. Compounds quantified were prostaglandins D2, E2, F2 alpha, 6-keto-F1 alpha, thromboxane B2, and 12-hydroxy-5,8,10,14-eicosatetraenoic acid. Mast cells incubated at 37 degrees C for 30 min without ionophore produced measurable quantities of all metabolites assayed. 4 microM A23187 resulted in substantial increased synthesis of all metabolites compared to control cells. Of the metabolites quantified, prostaglandin D2 and prostacyclin were the major products derived from arachidonic acid in ionophore-stimulated rat mast cells.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 389290     DOI: 10.1016/0005-2760(79)90020-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  24 in total

1.  Exaggerated atrial arachidonate metabolism in rabbit left ventricular myocardial infarction.

Authors:  A S Evers; C G Dunkel; J E Saffitz; P Needleman
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

2.  Oxatomide inhibits the release of bronchoconstrictor arachidonic acid metabolites (iLTC4 and PGD2) from rat mast cells and guinea-pig lung.

Authors:  Y Kosaka; H Kawabe; A Ishii
Journal:  Agents Actions       Date:  1987-06

Review 3.  Metabolites of arachidonic acid.

Authors:  W F Stenson; C W Parker
Journal:  Clin Rev Allergy       Date:  1983-09

Review 4.  Mast cell heterogeneity: evidence and implications.

Authors:  K E Barrett; D D Metcalfe
Journal:  J Clin Immunol       Date:  1984-07       Impact factor: 8.317

5.  Human mononuclear phagocytes from different anatomical sites differ in their capacity to metabolize arachidonic acid.

Authors:  E Vicenzi; A Biondi; C Bordignon; A Rambaldi; M B Donati; A Mantovani
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

6.  Stimulation of equine eosinophil migration by hydroxyacid metabolites of arachidonic acid.

Authors:  K A Potter; R W Leid; P E Kolattukudy; K E Espelie
Journal:  Am J Pathol       Date:  1985-11       Impact factor: 4.307

7.  Exocytosis in chromaffin cells: evidence for a MgATP-independent step that requires a pertussis toxin-sensitive GTP-binding protein.

Authors:  N Vitale; D Thiersé; D Aunis; M F Bader
Journal:  Biochem J       Date:  1994-05-15       Impact factor: 3.857

8.  Diphenhydramine blocks the leukotriene-C4 enhanced mucus secretion in canine trachea in vivo.

Authors:  H G Johnson; R A Chinn; D R Morton; M L McNee; M D Miller; J A Nadel
Journal:  Agents Actions       Date:  1983-02

9.  Lipoxygenation of arachidonic acid as a source of polymorphonuclear leukocyte chemotactic factors in synovial fluid and tissue in rheumatoid arthritis and spondyloarthritis.

Authors:  L B Klickstein; C Shapleigh; E J Goetzl
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808

10.  Transformation of prostaglandin D2 to 9 alpha, 11 beta-(15S)-trihydroxyprosta-(5Z,13E)-dien-1-oic acid (9 alpha, 11 beta-prostaglandin F2): a unique biologically active prostaglandin produced enzymatically in vivo in humans.

Authors:  T E Liston; L J Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.